| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211596 Stable high-concentration injection containing pyrazolone derivative |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
| 05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211399 Method for detecting leptin receptor ligands |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2320706C 20-hete antagonists and agonists |
| 05/01/2007 | CA2206748C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 05/01/2007 | CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2148632C Topical medicament having cicatrizing activity |
| 05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 05/01/2007 | CA2120303C Cyclic adhesion inhibitors |
| 04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
| 04/26/2007 | WO2007047724A2 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | WO2007047401A2 A1 adenosine receptor agonists |
| 04/26/2007 | WO2007046489A1 Therapeutic agent for heart disease |
| 04/26/2007 | WO2007045639A1 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| 04/26/2007 | WO2007045433A1 Dicarboxylic acid derivatives and their use |
| 04/26/2007 | WO2007045392A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007045370A1 Tetrazol derivatives and their use for the treatment of cardiovascular diseases |
| 04/26/2007 | WO2007045369A1 Difluorophenol derivatives and their use |
| 04/26/2007 | WO2007045367A1 Cyclopropylacetic acid derivatives and use thereof |
| 04/26/2007 | WO2007045366A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 04/26/2007 | WO2007045184A1 The peptides essence receptor antagonist which 2-site containing proline or crico-amino acid |
| 04/26/2007 | WO2007031501A3 Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure |
| 04/26/2007 | WO2007028133A3 Treatment and prevention of vascular dementia |
| 04/26/2007 | WO2007017145A3 Gsk-3 inhibitors |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2006128847A3 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| 04/26/2007 | WO2006128600A3 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine |
| 04/26/2007 | WO2006117165A3 Means and methods for the treatment of head injuries and stroke |
| 04/26/2007 | WO2006089871A3 Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias |
| 04/26/2007 | WO2006067173A3 Antithrombotic dual inhibitors comprising a biotin residue |
| 04/26/2007 | WO2006042724A3 Magnetic particles for therapy and diagnosis |
| 04/26/2007 | WO2006017921A8 Selective muscle relaxant and pharmaceutical compositions |
| 04/26/2007 | US20070093661 Method for the enantiomoeric separation of optical active amlodipine |
| 04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
| 04/26/2007 | US20070093482 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070093427 Membrane-permeable NFAT inhibitory peptide |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070092513 Antiproliferative agents; anticancer agents; controlling excessive proliferation or migration of smooth muscle cells by treating said smooth muscle cells with an effective amount of an antagonist of a native ErbB4 receptor |
| 04/26/2007 | DE10354862B4 Ramipril enthaltende feste pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung Ramipril containing solid pharmaceutical compositions and methods for their preparation |
| 04/26/2007 | DE102005050497A1 Difluorphenol-Derivate und ihre Verwendung Difluorophenol derivatives and their use |
| 04/26/2007 | DE102005049953A1 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen Carbamoylbenzotriazol derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | DE102005049637A1 Antagonisten gegen die Interaktion von PF4 und RANTES Antagonists to the interaction of PF4 and RANTES |
| 04/26/2007 | DE102005049293A1 Kombinationspräparate von Salzen oder o-Acetylsalicylsäure Combination preparations of salts or O-acetylsalicylic acid |
| 04/26/2007 | CA2626688A1 Agents for treating cardiopathy |
| 04/26/2007 | CA2626461A1 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | CA2626449A1 Heterocyclic compounds and their use |
| 04/26/2007 | CA2625783A1 A1 adenosine receptor agonists |
| 04/26/2007 | CA2625442A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2625416A1 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/26/2007 | CA2624648A1 Methods of decreasing vascular calcification using il-1 inhibitors |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders |
| 04/25/2007 | EP1776958A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776953A1 Solid oral dosage forms comprising valsartan |
| 04/25/2007 | EP1776951A1 Long chain alcohols for suppressing the concentration of C-reactive proteins (CRP) in human blood |
| 04/25/2007 | EP1776120A1 Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 04/25/2007 | EP1776108A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 04/25/2007 | EP1776099A1 Methods for improving bioavailability of a renin inhibitor |
| 04/25/2007 | EP1776095A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists |
| 04/25/2007 | EP1526867B1 Erythropoietin in subpolycythemic doses |
| 04/25/2007 | EP1490401B1 Vegf peptides and their use |
| 04/25/2007 | EP1487834B1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1421120B1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1210425B1 Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2007 | EP1142586B1 Use of chymase inhibitors against vascular lipid deposition |
| 04/25/2007 | EP1100780B1 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZ[F]INDOLES, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS |